• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATM 低表达表明透明细胞肾细胞癌预后不良。

Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

机构信息

Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China.

Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China.

出版信息

Clin Genitourin Cancer. 2019 Jun;17(3):e433-e439. doi: 10.1016/j.clgc.2019.01.003. Epub 2019 Jan 10.

DOI:10.1016/j.clgc.2019.01.003
PMID:30773312
Abstract

INTRODUCTION

The study was carried out to examine the expression of ataxia telangiectasia mutant (ATM) of clear cell renal cell carcinoma (ccRCC), and to explore the relationship between the expression of ATM and the clinicopathologic parameters and prognosis of ccRCC.

MATERIALS AND METHODS

Clinicopathologic data of the patients with ccRCC were collected from January 2011 to August 2015 in Xiangya Hospital, Central South University. The immunohistochemical method was used to detect the expression of ATM in ccRCC and adjacent tissues. The Kaplan-Meier survival method and log-rank test were used to analyze the relationship between ATM expression and the survival time of the patients with ccRCC. Univariate and multivariate Cox regression analysis was used to evaluate the risk factors for the prognosis of ccRCC.

RESULTS

A total of 110 patients were selected in this study, including 73 men and 37 women. The expression of ATM in ccRCC is significantly lower than that in adjacent tissues. Further analysis found that the expression of ATM in the ccRCC tissues above grade II was lower than that of grade II or below. Kaplan-Meier survival analysis showed that the total survival time of the ATM low expression group was significantly shorter than that of the ATM high expression group. The multivariate Cox regression analysis showed that expression of ATM and clinical stage were independent factors affecting the prognosis of ccRCC.

CONCLUSION

ATM expression level could serve as an independent risk factor for the prognosis of ccRCC and could be considered as a potential therapeutic target of ccRCC.

摘要

简介

本研究旨在检测常染色体显性遗传小脑共济失调毛细血管扩张症突变(ATM)在透明细胞肾细胞癌(ccRCC)中的表达情况,并探讨其与 ccRCC 临床病理参数及预后的关系。

材料与方法

收集 2011 年 1 月至 2015 年 8 月在中南大学湘雅医院接受治疗的 ccRCC 患者的临床病理资料。采用免疫组织化学法检测 ccRCC 及相邻组织中 ATM 的表达情况。采用 Kaplan-Meier 生存法和 Log-rank 检验分析 ATM 表达与 ccRCC 患者生存时间的关系。采用单因素和多因素 Cox 回归分析评估 ccRCC 预后的危险因素。

结果

本研究共纳入 110 例患者,其中男 73 例,女 37 例。ccRCC 组织中 ATM 的表达明显低于相邻组织。进一步分析发现,Ⅱ级以上 ccRCC 组织中 ATM 的表达低于Ⅱ级或以下。Kaplan-Meier 生存分析显示,ATM 低表达组的总生存时间明显短于 ATM 高表达组。多因素 Cox 回归分析显示,ATM 表达水平和临床分期是影响 ccRCC 预后的独立因素。

结论

ATM 表达水平可作为 ccRCC 预后的独立危险因素,可作为 ccRCC 的潜在治疗靶点。

相似文献

1
Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.ATM 低表达表明透明细胞肾细胞癌预后不良。
Clin Genitourin Cancer. 2019 Jun;17(3):e433-e439. doi: 10.1016/j.clgc.2019.01.003. Epub 2019 Jan 10.
2
Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.N-乙酰半乳糖胺基转移酶10的高表达预示着透明细胞肾细胞癌患者的不良生存和早期复发。
Ann Surg Oncol. 2015 Jul;22(7):2446-53. doi: 10.1245/s10434-014-4236-y. Epub 2014 Nov 13.
3
High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.高粘蛋白-7表达是透明细胞肾细胞癌患者不良临床结局的独立预测指标。
Tumour Biol. 2016 Nov;37(11):15193-15201. doi: 10.1007/s13277-016-5375-5. Epub 2016 Sep 28.
4
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.低水平的异柠檬酸脱氢酶 1 可预测透明细胞肾细胞癌患者术后的不良结局。
BMC Cancer. 2018 Aug 28;18(1):852. doi: 10.1186/s12885-018-4747-1.
5
Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.血小板衍生生长因子受体-β表达在局限性透明细胞肾细胞癌中的预后意义
J Cancer Res Clin Oncol. 2015 Dec;141(12):2213-20. doi: 10.1007/s00432-015-2019-x. Epub 2015 Jul 28.
6
Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.CTR2表达降低预示着透明细胞肾细胞癌患者的预后不良。
Urol Oncol. 2016 Jan;34(1):5.e1-9. doi: 10.1016/j.urolonc.2015.08.013. Epub 2015 Sep 26.
7
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.TPX2作为透明细胞肾细胞癌的预后指标和潜在治疗靶点。
Urol Oncol. 2017 May;35(5):286-293. doi: 10.1016/j.urolonc.2016.12.012. Epub 2017 Jan 17.
8
Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.集落刺激因子-1表达增加是透明细胞肾细胞癌患者预后不良的一个预测指标。
BMC Cancer. 2015 Feb 18;15:67. doi: 10.1186/s12885-015-1076-5.
9
RAB27A is an independent prognostic factor in clear cell renal cell carcinoma.RAB27A 是肾透明细胞癌的一个独立预后因素。
Biomark Med. 2019 Mar;13(4):239-247. doi: 10.2217/bmm-2018-0336. Epub 2019 Jan 21.
10
High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.粘蛋白13的高表达与非转移性透明细胞肾细胞癌患者术后更严峻的预后相关。
Oncotarget. 2017 Jan 31;8(5):7548-7558. doi: 10.18632/oncotarget.13692.

引用本文的文献

1
Dual cancers in Ataxia-Telangiectasia: a case report and literature review.共济失调毛细血管扩张症中的双原发癌:一例报告及文献综述
Neurol Sci. 2025 Aug 23. doi: 10.1007/s10072-025-08417-y.
2
Radiogenomics of Stereotactic Radiotherapy: Genetic Mechanisms Underlying Radiosensitivity, Resistance, and Immune Response.立体定向放射治疗的放射基因组学:放射敏感性、抗性和免疫反应背后的遗传机制。
Genes (Basel). 2025 Jun 24;16(7):732. doi: 10.3390/genes16070732.
3
Low-grade oncocytic tumor of the kidney-a clinical, pathological, and next generation sequencing-based study of 20 tumors.
肾低度嗜酸细胞瘤——20例肿瘤的临床、病理及基于二代测序的研究
Pathol Oncol Res. 2025 Jun 2;31:1612150. doi: 10.3389/pore.2025.1612150. eCollection 2025.
4
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.致病性 ATM 和 BAP1 种系突变致早发家族性肉瘤样肾细胞癌。
Cold Spring Harb Mol Case Stud. 2022 Apr 28;8(3). doi: 10.1101/mcs.a006203. Print 2022 Apr.